ST. LOUIS — When Deborah Giannecchini was diagnosed with stage 4 ovarian cancer four years ago, it didn’t make sense. She had no family history, nor did she seem a high risk.
But months later, when her daughter saw a TV ad for a law firm asking ovarian cancer victims who used talcum powder to come forward, Giannecchini realized a possible link: She had been using Johnson & Johnson’s baby powder for most of her life.
“I used it for 45 years, from age 15,” Giannecchini, now 63, said Friday. “I was still using it.”
On Thursday, a St. Louis jury awarded more than $70 million to Giannecchini, of Modesto, California, wrapping up a month-long trial. It was the third big verdict awarded by a St. Louis jury against Johnson & Johnson in ovarian cancer lawsuits this year. Combined, the three awards amount to nearly $200 million.
Giannecchini said she was happy with the verdict, but it doesn’t make up for the cancer fight and ongoing health problems caused by chemotherapy.
“There’s not enough money in the world to pay for fighting the cancer,” she said at a news conference arranged by her lawyers.
A spokeswoman for Johnson & Johnson said in a statement that while the company sympathizes with women and their families impacted by ovarian cancer, it will appeal the latest verdict “because we are guided by the science, which supports the safety of Johnson’s Baby Powder.”
About 2,000 women nationwide have filed similar suits over concerns about health damage caused by extended talcum powder use. Lawyers are reviewing many additional cases, many of them generated by television ads by law firms.
